Shigeki Momohara - Concepedia

Author

Shigeki Momohara

Tokyo Women's Medical University ORCID

Also Known As

S Momohara, S. Momohara, SHIGEKI MOMOHARA, Shigeki MOMOHARA, Shigeki Momohara

337

Publications

10.2K

Citations

H-Index

141

Concepts

All Affiliations

Tokyo Women's Medical University Keio University The University of Tokyo Kyoto University

About

Shigeki Momohara is an author at Tokyo Women's Medical University specializing in rheumatology, rheumatoid arthritis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	89	2.8K
2	Public Health	18	23	592
3	Health Sciences	8	8	218
4	Engineering	1	1	19
5	Natural Sciences	1	1	27

Shigeki Momohara

161

Publications

Citations

H-Index

Page 1

	Year	Citations
A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility Yuta Kochi, Yukinori Okada, Akari Suzuki, Nature Genetics InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRegulatory Variant	2010	266
Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA Ayako Nakajima, Eisuke Inoue, Eiichi Tanaka, Scandinavian Journal of Rheumatology	2010	169
Association of <i>STAT4</i> with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population Shu Kobayashi, Katsunori Ikari, Hirotaka Kaneko, Arthritis & Rheumatism	2008	160
Association between <i>PADI4</i> and rheumatoid arthritis: A replication study Katsunori Ikari, M. Kuwahara, Takahiro Nakamura, Arthritis & Rheumatism	2005	151
A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis Satomi Kobayashi, Hiroshi Okamoto, Takuji Iwamoto, Lara D. Veeken	2008	148
Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I) Hisashi Yamanaka, Naonobu Sugiyama, Eisuke Inoue, Modern Rheumatology	2013	143
Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor- blockers: perioperative interruption of tumour necrosis factor- blockers decreases complications? Kosei Kawakami, Katsunori Ikari, Koichiro Kawamura, Lara D. Veeken	2009	132
Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Hiroshi Okamoto, Takuji Iwamoto, Shigeru Kotake, PubMed	2005	117
Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population Katsunori Ikari, Shigeki Momohara, Eisuke Inoue, Lara D. Veeken	2006	115
Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs Shigeki Momohara, Kosei Kawakami, Takuji Iwamoto, Modern Rheumatology Non-operative ManagementSurgeryOrthopaedic SurgeryInflammatory ArthritisRheumatoid Disorder	2011	115

Page 1